Great Point Partners LLC Geron Corp Transaction History

Great Point Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $3.26 Million - $4.78 Million	-2,610,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $3.72 Million - $5.13 Million	-2,445,189 Reduced 48.37%	2,610,000 $4.12 Million
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $7.18 Million - $9.49 Million	-4,630,339 Reduced 47.81%	5,055,189 $8.04 Million
Q3 2020 Nov 16, 2020	SELL	$1.59 - $2.19 $9.08 Million - $12.5 Million	-5,712,551 Reduced 37.1%	9,685,528 $16.9 Million
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $16.2 Million - $33.6 Million	15,398,079 New	15,398,079 $33.6 Million

276

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.14B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.